Robert D. Sullivan

1.2k total citations
32 papers, 909 citations indexed

About

Robert D. Sullivan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Robert D. Sullivan has authored 32 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Robert D. Sullivan's work include Colorectal Cancer Treatments and Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Head and Neck Cancer Studies (4 papers). Robert D. Sullivan is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Head and Neck Cancer Studies (4 papers). Robert D. Sullivan collaborates with scholars based in United States and Canada. Robert D. Sullivan's co-authors include Edward Miller, Elton Watkins, Ralph Jones, I. H. Krakoff, L. L. Anderson, Truman G. Schnabel, Bayard D. Clarkson, Peter Clifford, John F. Atkins and Richard A. Oberfield and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Robert D. Sullivan

28 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert D. Sullivan United States 14 366 266 255 198 110 32 909
Theodor B. Grage United States 18 624 1.7× 542 2.0× 336 1.3× 176 0.9× 34 0.3× 43 1.1k
Vishram B. Rege United States 14 484 1.3× 105 0.4× 449 1.8× 61 0.3× 63 0.6× 19 827
Salitha Reddy United States 18 571 1.6× 200 0.8× 552 2.2× 51 0.3× 68 0.6× 29 1.3k
John A. Stryker United States 24 323 0.9× 449 1.7× 341 1.3× 33 0.2× 35 0.3× 54 1.4k
J. F. Pringle Canada 18 480 1.3× 363 1.4× 310 1.2× 38 0.2× 29 0.3× 22 1.3k
James D. Ahlgren United States 15 1.1k 3.1× 343 1.3× 359 1.4× 101 0.5× 36 0.3× 36 1.4k
Sandra J. Casak United States 18 455 1.2× 189 0.7× 215 0.8× 114 0.6× 58 0.5× 32 1.0k
T Buroker United States 18 835 2.3× 603 2.3× 531 2.1× 118 0.6× 21 0.2× 21 1.4k
C.G. Alexopoulos Greece 15 421 1.2× 123 0.5× 219 0.9× 118 0.6× 12 0.1× 34 789
Steven E. Vogl United States 21 749 2.0× 458 1.7× 554 2.2× 22 0.1× 250 2.3× 55 1.4k

Countries citing papers authored by Robert D. Sullivan

Since Specialization
Citations

This map shows the geographic impact of Robert D. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Sullivan more than expected).

Fields of papers citing papers by Robert D. Sullivan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Sullivan. The network helps show where Robert D. Sullivan may publish in the future.

Co-authorship network of co-authors of Robert D. Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Robert D. Sullivan. A scholar is included among the top collaborators of Robert D. Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert D. Sullivan. Robert D. Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sullivan, Robert D., Nataliia V. Shults, & Yuichiro Suzuki. (2023). Case Report: Two Case Reports of Pulmonary Hypertension after mRNA COVID-19 Vaccination. SHILAP Revista de lepidopterología. 11(3). 114–114. 1 indexed citations
2.
Sullivan, Robert D., et al.. (1999). Le capital social et l’amélioration de la santé et du bien-être des populations. Canadian Journal of Public Health. 90(6). 369–371. 3 indexed citations
3.
Sullivan, Robert D.. (1976). Comment: Disseminated cancer—metastases to liver. International Journal of Radiation Oncology*Biology*Physics. 1(9-10). 991–992. 1 indexed citations
4.
Anderson, L. L., et al.. (1970). A study of the distribution of methotrexate in human tissues and tumors.. PubMed. 30(5). 1344–8. 62 indexed citations
5.
Sullivan, Robert D., et al.. (1967). Current Status of Protracted Arterial Infusion Cancer Chemotherapy for the Treatment of Solid Tumors. Surgical Clinics of North America. 47(3). 769–784. 13 indexed citations
6.
Sullivan, Robert D. & Richard A. Oberfield. (1966). Chemotherapy of Metastatic Gastrointestinal Cancer. Medical Clinics of North America. 50(2). 427–438. 2 indexed citations
7.
Sullivan, Robert D.. (1965). Chemotherapy for Liver Cancer by Protracted Ambulatory Infusion. JAMA. 194(5). 481–481. 69 indexed citations
8.
Sullivan, Robert D. & Edward Miller. (1965). The clinical effects of prolonged intravenous infusion of 5-fluoro-2'-deoxyuridine.. PubMed. 25(7). 1025–33. 28 indexed citations
9.
Watkins, Elton, et al.. (1964). Hepatic Artery Catheterization for Prolonged Infusion Chemotherapy of Liver Cancer. Surgical Clinics of North America. 44(3). 763–778. 16 indexed citations
10.
Sullivan, Robert D., et al.. (1964). Chemotherapy of Metastatic Liver Cancer by Prolonged Hepatic-Artery Infusion. New England Journal of Medicine. 270(7). 321–327. 123 indexed citations
11.
Sullivan, Robert D., et al.. (1962). Effects of different dose schedules of amethopterin on serum and tissue concentrations and urinary excretion patterns. Clinical Pharmacology & Therapeutics. 3(1). 34–40. 27 indexed citations
12.
Sullivan, Robert D.. (1962). Continuous Arterial Infusion Cancer Chemotherapy. Surgical Clinics of North America. 42(2). 365–388. 39 indexed citations
15.
16.
Sullivan, Robert D.. (1958). MYLERAN THERAPY IN BRONCHOGENIC CARCINOMA. Annals of the New York Academy of Sciences. 68(3). 1038–1045. 11 indexed citations
17.
Lane, Montague, John L. Fahey, Robert D. Sullivan, & C. Gordon Zubrod. (1958). The comparative pharmacology in man and the rat of the riboflavin analogu 6,7-dimethyl-9-(2-acetoxyethyl)-isoalloxazine, U-2112.. PubMed. 122(3). 315–26. 9 indexed citations
18.
Lane, Montague, John L. Fahey, Robert D. Sullivan, & C. Gordon Zubrod. (1958). THE COMPARATIVE PHARMACOLOGY IN MAN AND THE RAT OF THE RIBOFLAVIN ANALOGUE, 6,7-DIMETHYL-9-(2'-ACETOXYETHYL)-ISOALLOXAZINE, U-2112. Journal of Pharmacology and Experimental Therapeutics. 122(3). 315–326. 9 indexed citations
20.
Atkins, John F., Robert D. Sullivan, & Ralph Jones. (1951). Lxxvii Endobronchial Lymphoma and its Simulation by Bronchogenic Carcinoma. Annals of Otology Rhinology & Laryngology. 60(3). 849–863. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026